Complex t(8;14;21)(q22;q13;q22), a variant of t(8;21), with t(15;21)(q15;p11) in a patient with acute myelogenous leukemia (M1).
Takahashi
Tohru
T
Maruyama
Yumiko
Y
Satoh
Yukihiko
Y
Yoshimoto
Mitsuru
M
Tsujisaki
Masayuki
M
D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D002883:Chromosomes, Human, Pair 14; D002884:Chromosomes, Human, Pair 15; D002891:Chromosomes, Human, Pair 21; D002898:Chromosomes, Human, Pair 8; D050676:Core Binding Factor Alpha 2 Subunit; D003561:Cytarabine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D014644:Genetic Variation; D006801:Humans; D015255:Idarubicin / Q000627:therapeutic use; D007621:Karyotyping; D015470:Leukemia, Myeloid, Acute / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics* / Q000517:prevention & control*; D007963:Leukocytes, Mononuclear / Q000737:chemistry; D008875:Middle Aged; D015514:Oncogene Proteins, Fusion / Q000235:genetics; D012333:RNA, Messenger / Q000235:genetics; D000075142:RUNX1 Translocation Partner 1 Protein; D020133:Reverse Transcriptase Polymerase Chain Reaction; D055502:Secondary Prevention; D014157:Transcription Factors / Q000235:genetics; D014178:Translocation, Genetic
C107844:AML1-ETO fusion protein, human; D000964:Antimetabolites, Antineoplastic; D050676:Core Binding Factor Alpha 2 Subunit; D015514:Oncogene Proteins, Fusion; D012333:RNA, Messenger; D000075142:RUNX1 Translocation Partner 1 Protein; D014157:Transcription Factors; D003561:Cytarabine; D015255:Idarubicin